Skip to main content
Livermore
Livermore
ZHEN

Squarepoint Ops LLC

SEC CIK
0001642575
Latest filing
Aug 14, 2026

RIGL holding history

Rigel Pharmaceuticals Inc in every 13F filed by Squarepoint Ops LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RIGL overviewAll 13F holders of RIGLFull Q2 2026 holdings

Shares (Q2 2026)
66,658
Value
$2.61M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of RIGL by Squarepoint Ops LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202666,658$2.61M<0.1%+38,550+137.1%AddedHolders
Q1 202628,108$760.0K<0.1%−25,448−47.5%ReducedHolders
Q4 202553,556$2.29M<0.1%−119,082−69.0%ReducedHolders
Q3 2025172,638$4.89M<0.1%+136,423+376.7%AddedHolders
Q2 202536,215$678.3K<0.1%+14,135+64.0%AddedHolders
Q1 202522,080$397.2K<0.1%−41,336−65.2%ReducedHolders
Q4 202463,416$1.07M<0.1%+18,159+40.1%AddedHolders
Q3 202445,257$732.3K<0.1%−35,653−44.1%ReducedHolders
Q2 202480,910$665.1K<0.1%+21,078+35.2%AddedConverted for a 1-for-10 splitHolders
Q1 2024598,324$885.5K<0.1%+274,533+84.8%AddedHolders
Q4 2023323,791$469.5K<0.1%+323,791NewHolders
Q3 20230$00.0%−19,929−100.0%Sold outHolders
Q2 202319,929$25.7K<0.1%+19,929NewHolders
Q1 20230$00.0%−28,006−100.0%Sold outHolders
Q4 202228,006$42.0K<0.1%−538,809−95.1%ReducedHolders
Q3 2022566,815$669.0K<0.1%+566,815NewHolders
Q2 20220$00.0%−17,644−100.0%Sold outHolders
Q1 202217,644$53.0K<0.1%−135,176−88.5%ReducedHolders
Q4 2021152,820$405.0K<0.1%−186,738−55.0%ReducedHolders
Q3 2021339,558$1.23M<0.1%+78,052+29.8%AddedHolders
Q2 2021261,506$1.14M<0.1%+162,364+163.8%AddedHolders
Q1 202199,142$339.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.